WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eisai Inc. and its parent company Eisai Co., Ltd. today announce the establishment of a subsidiary company in Brazil, which will be named Eisai Participações Ltda. (Eisai Brazil). As a direct subsidiary of Eisai Inc., Eisai Brazil will be based in Sao Paulo, the country’s largest city.
“The establishment of Eisai Brazil marks our entry into Latin America,” said Hajime Shimizu, President, New Markets and ASEAN, Eisai Co., Ltd. “In keeping with Eisai’s human health care (hhc) mission to satisfy unmet medical needs and contribute to the health and well-being of people worldwide, this expansion will enable us to introduce many of Eisai’s first-in-class products to people living in Brazil.”
Eisai Brazil’s immediate focus will be on establishing an initial infrastructure to support its operations debut into the Brazilian market. The company’s areas of commercial focus will include neurology, oncology and critical care.
Eisai Inc.
Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business. Eisai’s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.
Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company’s areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com/us.
Eisai Co., Ltd.
Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system.
Contact:
Eisai Inc. Media Inquiries Suzanne Grogan, 201-746-2083 Investor Inquiries Alex Scott, 201-746-2177
